Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Immunization with mimotopes prevents growth of carcinoembryonic antigen positive tumors in BALB/c miceKira H Brämswig, Regina Knittelfelder, Silke Gruber, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized MiceChristoph Schifflers, Samantha Zottnick, Jonas D Förster, et al.
Allergy|August 2, 2008
AllergoOncology: the role of IgE-mediated allergy in cancerE Jensen-Jarolim, G Achatz, M C Turner, et al.
Molecular Immunology|December 14, 2004
Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigenElisabeth Förster-Waldl, Angelika B Riemer, Anna Katharina Dehof, et al.
The Journal of Investigative Dermatology|December 4, 2009
3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse modelVerena Paulitschke, Nikolaus Schicher, Thomas Szekeres, et al.
Journal for Immunotherapy of Cancer|June 3, 2025
Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancerMichael Volkmar, Dana Hoser, Claudia Lauenstein, et al.
Oncoimmunology|February 7, 2019
A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivoMathias Vormehr, Katharina Reinhard, Renata Blatnik, et al.
Cancer Immunology Research|December 25, 2019
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggetsXiaoshan M Shao, Rohit Bhattacharya, Justin Huang, et al.
Cancer Research|November 3, 2006
Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastasesStefan Fest, Nicole Huebener, Silke Weixler, et al.
Pageof 7